Market Overview

Biolase, Inc. (NASDAQ: BIOL)

1.07 +0.04 (3.88%)

Earnings

QuarterPriorEstimateActualSurprise
Q2 2020
After-Hours
EPS:
REV:




Q1 2020
After-Hours
EPS:
REV:
-0.15
10.326M



Q4 2019
After-Hours
EPS:
REV:
-0.13
13.045M



Q3 2019
Pre-Market
EPS:
REV:
-0.19
10.936M



Q2 2019
After-Hours
EPS:
REV:
-0.20
12.154M
-0.12
12.58M
-0.13
8.645M
-8.33%
-31.28%
Q1 2019
After-Hours
EPS:
REV:
-0.04
10.02M
-0.18
10.43M
-0.15
10.326M
16.67%
-1%
Q4 2018
After-Hours
EPS:
REV:
-0.04
12.634M
-0.17
13.01M
-0.13
13.045M
-23.53%
0.27%
Q3 2018
Pre-Market
EPS:
REV:
-0.05
10.806M
-0.19
11.52M
-0.19
10.936M

-5.07%
Q2 2018
Pre-Market
EPS:
REV:
-0.05
12.612M
-0.20
12.75M
-0.20
12.154M

-4.67%
Q1 2018
After-Hours
EPS:
REV:
-0.05
10.874M
-0.05
10.96M
-0.04
10.02M
-20%
-8.58%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!